Trial intelligence / Profile preview

Intensified Prasugrel vs High-Dose Clopidogrel Loading in Biomarker-Negative Angina Undergoing PCI

2014-002171-29Phase 4Terminated

Sponsor
LMU Klinikum
Start
Apr 2015
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised trial in coronary arteriosclerosis, unstable angina and stable angina comparing Prasugrel intensified loading with Clopidogrel high-dose loading (2 arms). Primary endpoint: Composite ischemic outcome at 30 days. Started Apr 2015; status: terminated.

02

Drugs

prasugrelclopidogrel
03

Conditions

coronary arteriosclerosisunstable anginastable angina

Beyond the preview

Go deeper on 2014-002171-29.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2014-002171-29.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call